PureData eBook - Antiseptics & Antibacterial Preparations in ... - cover

PureData eBook - Antiseptics & Antibacterial Preparations in ...

Editorial Datagroup Asia

  • 30 september 2018
  • 1230002595061
Wil ik lezen
  • Wil ik lezen
  • Aan het lezen
  • Gelezen
  • Verwijderen

Samenvatting:

The Antiseptics & Antibacterial Preparations South Korea eBook provides 14 years Historic and Forecast data on the market for each of the 26 Products and Markets covered. The Products and Markets covered (Antiseptics & antibacterial preparations) are classified by the Major Products and then further defined and analysed by each subsidiary Product or Market Sector. In addition full Financial Data (188 items: Historic and Forecast Balance Sheet, Financial Margins and Ratios) Data is provided, as well as Industry Data (59 items) for South Korea.

ANTISEPTICS + ANTIBACTERIAL PREPARATIONS

  1. Antiseptics & antibacterial preparations
  2. Acriflavine
  3. Antibacterial pharmaceuticals
  4. Anti-gonococcals
  5. Anti-leprosy products
  6. Anti-malarials
  7. Antisepticemics
  8. Antiseptics, all-purpose
  9. Antiseptics, dental & stomatological
  10. Antiseptics, dermatological
  11. Antiseptics, gastrointestinal tract
  12. Antiseptics, ophthalmic
  13. Antiseptics, pulmonary
  14. Antiseptics, surgical
  15. Antiseptics, upper respiratory tract
  16. Antiseptics, urinary
  17. Antiseptics, vascular
  18. Anti-spirillaries
  19. Anti-syphilitics
  20. Anti-trichomonal agents
  21. Anti-tuberculosis preparations/tuberculostatics
  22. Isoniazid/isonicotinic acid hydrazide
  23. Skin & wound disinfectants
  24. Surgical spirit
  25. Triclosan
  26. Antiseptics & antibacterial preparations, NSK

There are 188 Financial items covered, including:
Total Sales, Pre-tax Profit, Interest Paid, Non-trading Income, Operating Profit, Depreciation: Structures, Depreciation: P + E, Depreciation: Misc., Total Depreciation, Trading Profit, Intangible Assets, Intermediate Assets, Fixed Assets: Structures, Fixed Assets: P + E, Fixed Assets: Misc., Total Fixed Assets, Capital Expenditure: Structures, Capital Expenditure: P + E, Capital Expenditure: Vehicles, Capital Expenditure: Data Processing, Capital Expenditure: Misc., Total Capital Expenditure, Retirements: Structures, Retirements: P + E, Retirements: Misc., Total Retirements, Total Fixed Assets, Finished Product Stocks, Work in Progress as Stocks, Materials as Stocks, Total Stocks / Inventory, Debtors, Total Maintenance Costs, Services Purchased, Misc. Current Assets, Total Current Assets, Total Assets, Creditors, Short Term Loans, Misc. Current Liabilities, Total Current Liabilities, Net Assets / Capital Employed, Shareholders Funds, Long Term Loans, Misc. Long Term Liabilities, Workers, Hours Worked, Total Employees, Raw Materials Cost, Finished Materials Cost, Fuel Cost, Electricity Cost, Total Input Supplies / Materials + Energy Costs, Payroll Costs, Wages, Director Remunerations, Employee Benefits, Employee Commissions, Total Employees Remunerations, Sub Contractors, Rental & Leasing: Structures, Rental & Leasing: P + E, Total Rental & Leasing Costs, Maintenance: Structures, Maintenance: P + E, Communications Costs, Misc. Expenses, Sales Personnel Variable Costs, Sales Expenses + Costs, Sales Materials Costs, Total Sales Costs, Distribution Fixed + Variable Costs, Premises Fixed Costs, Premises Variable Costs, Physical Handling Fixed + Variable Costs, Physical Process Fixed + Variable Costs, Total Distribution Costs, Correspondence Costs, Media Advertising Costs, Advertising Materials Costs, POS & Display Costs, Events Costs, Total Advertising Costs, Product Handling Costs, Product Support Costs, Product Service Costs, Customer Problem Solving Costs, Total After-Sales Costs, Total Marketing Costs, New Technology Expenditure, New Production Technology Expenditure, Total Research + Development Expenditure, Total Operational & Process Costs, Debtors + Agreed Terms, Un-recoverable Debts.
/.. etc.

We gebruiken cookies om er zeker van te zijn dat je onze website zo goed mogelijk beleeft. Als je deze website blijft gebruiken gaan we ervan uit dat je dat goed vindt. Ok